会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Testing communication during implantation
    • 测量植入过程中的沟通
    • US08983619B2
    • 2015-03-17
    • US12732403
    • 2010-03-26
    • Can CinbisH. Toby Markowitz
    • Can CinbisH. Toby Markowitz
    • A61N1/08A61B5/00A61N1/372A61B19/00A61N1/375
    • A61B5/0028A61B5/0031A61B2034/2053A61B2560/0271A61N1/37205A61N1/37217A61N1/37241A61N1/3756
    • A system and method are described for testing communication through a patient during implantation using telemetry coupling electrodes on a delivery catheter. In one example, at least two telemetry coupling electrodes may be placed on or within a delivery catheter to test conductive communication with external body electrodes during implantation. In some instances, the telemetry coupling electrodes of the delivery catheter may approximate the spacing of telemetry electrodes on an IMD. In this manner, testing conductively coupled communication with telemetry coupling electrodes of the catheter may be used to mimic the telemetry electrodes on the IMD and determine a target position and/or orientation of an electrode or electrodes of the IMD for successful conductive communication through the body.
    • 描述了一种系统和方法,用于在植入期间通过患者使用传送导管上的遥测耦合电极来测试通信。 在一个示例中,至少两个遥测耦合电极可以放置在输送导管上或内部,以在植入期间测试与外部身体电极的导电连通。 在一些情况下,输送导管的遥测耦合电极可以接近IMD上遥测电极的间距。 以这种方式,测试与导管的遥测耦合电极的导电耦合通信可以用于模拟IMD上的遥测电极,并且确定IMD的电极或电极的目标位置和/或取向以便通过身体成功地导电连通 。
    • 5. 发明授权
    • Tissue oxygenation monitoring in heart failure
    • 心力衰竭组织氧合监测
    • US08571620B2
    • 2013-10-29
    • US12797816
    • 2010-06-10
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • A61B5/00
    • A61N1/36557
    • A medical device system and associated method are used for monitoring a heart failure patient. A medical device for monitoring delivery of a therapy includes a sensor sensing an optical sensor signal corresponding to light attenuation by a volume of body tissue of a patient, a therapy delivery module to deliver a therapy, and a processor configured to compute a first tissue oxygenation measurement from the optical sensor signal prior to initiating delivery of the therapy, compute a second tissue oxygenation measurement from the optical sensor signal subsequent to initiating delivery of the therapy, compare the first and the second tissue oxygenation measurements, and determine whether the delivered therapy was successful in response to the first tissue oxygenation measurement and the second tissue oxygenation measurement.
    • 医疗器械系统和相关方法用于监测心力衰竭患者。 用于监测治疗递送的医疗装置包括传感器,其感测对应于患者的身体组织的体积的光衰减的光学传感器信号,用于递送治疗的治疗递送模块和被配置为计算第一组织氧合的处理器 在开始递送治疗之前从光学传感器信号进行的测量,在开始递送治疗之后从光学传感器信号计算第二组织氧合测量,比较第一和第二组织氧合测量,并确定递送的治疗是否为 成功地响应于第一次组织氧合测量和第二次组织氧合测量。
    • 6. 发明授权
    • Wireless cardiac pulsatility sensing
    • 无线心脏搏动检测
    • US08244339B2
    • 2012-08-14
    • US12852740
    • 2010-08-09
    • Xiaonan ShenCan Cinbis
    • Xiaonan ShenCan Cinbis
    • A61B5/04
    • A61B5/6846A61B5/0245A61B5/0538A61N1/3937A61N1/3956A61N1/3987
    • An implantable medical device system and associated method monitor changes in transimpedance in a body tissue due to changes in cardiac pulsatility. A first dipole is used to deliver a non-stimulating electrical current. The first dipole includes a first electrode and a second electrode adapted to be deployed along a first body location. A second dipole is used to measure a voltage resulting from the non-stimulating electrical current being conducted through a portion of a patient's body. The second dipole includes a third electrode and a fourth electrode different than the first electrode and the second electrode and adapted to be deployed along a second body location spaced apart from the first body location.
    • 可植入医疗装置系统和相关方法监测由于心脏搏动的变化而导致的身体组织中的跨阻抗变化。 第一偶极子用于传递非刺激电流。 第一偶极子包括适于沿着第一身体位置展开的第一电极和第二电极。 使用第二偶极子来测量通过患者身体的一部分传导的非刺激性电流产生的电压。 第二偶极子包括不同于第一电极和第二电极的第三电极和第四电极,并且适于沿着与第一主体位置间隔开的第二主体位置展开。
    • 9. 发明申请
    • Tissue Oxygenation Monitoring in Heart Failure
    • 心力衰竭组织氧合监测
    • US20100317942A1
    • 2010-12-16
    • US12797816
    • 2010-06-10
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • A61B5/00
    • A61N1/36557
    • A medical device system and associated method are used for monitoring a heart failure patient. A medical device for monitoring delivery of a therapy includes a sensor sensing an optical sensor signal corresponding to light attenuation by a volume of body tissue of a patient, a therapy delivery module to deliver a therapy, and a processor configured to compute a first tissue oxygenation measurement from the optical sensor signal prior to initiating delivery of the therapy, compute a second tissue oxygenation measurement from the optical sensor signal subsequent to initiating delivery of the therapy, compare the first and the second tissue oxygenation measurements, and determine whether the delivered therapy was successful in response to the first tissue oxygenation measurement and the second tissue oxygenation measurement.
    • 医疗器械系统和相关方法用于监测心力衰竭患者。 用于监测治疗递送的医疗装置包括传感器,其感测对应于患者的身体组织的体积的光衰减的光学传感器信号,用于递送治疗的治疗递送模块和被配置为计算第一组织氧合的处理器 在开始递送治疗之前从光学传感器信号进行的测量,在开始递送治疗之后从光学传感器信号计算第二组织氧合测量,比较第一和第二组织氧合测量,并确定递送的治疗是否为 成功地响应于第一次组织氧合测量和第二次组织氧合测量。